Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,019,423
+$2,956,203 QoQ
Shares Held
632,734
+4.4% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. TGTX ranks #80 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in TGTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,019,423 | 632,734 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,063,220 | 605,945 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,624,764 | 958,471 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $55,696,107 | 1,547,544 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,398,518 | 390,528 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,942,739 | 297,101 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,906,285 | 81,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,564,114 | 87,921 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,302,021 | 85,603 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,376,443 | 80,588 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $445,914 | 53,339 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,403,287 | 298,039 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,120,389 | 74,494 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,096,238 | 92,666 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $619,131 | 104,583 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $426,092 | 100,257 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,525,072 | 580,975 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,038,848 | 580,992 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $47,428,925 | 1,425,148 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $73,066,822 | 1,883,651 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $77,955,836 | 1,617,341 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $72,871,956 | 1,400,845 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,365,000 | 51,009 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||